The patient was diagnosed with CML because of over-expression of the BCR-ABL (P210) gene in the bone marrow (BM), 1 year after receiving the diagnosis of AIHA. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.